Patients are increasingly demanding natural-looking results with minimal downtime.

• The aesthetic services market is projected to reach $21.16 billion in 2025, driven by growing demand across all age groups.
• The market is expected to expand to $28.39 billion by 2029, with a strong focus on personalization and combination therapies. 

InMode helps you capture this growing market with revolutionary technologies and platforms such as Morpheus8, offering multiple modalities in single systems.

• The aesthetic services market size reached $19.7 billion in 2024, with non-surgical and minimally invasive procedures leading the growth.
• Major trends include technological advancements, rise of combination therapies, and increasing focus on preventive aesthetic treatments.
• The market's CAGR of 7.6% through 2029 reflects strong consumer demand for both body and facial treatments.

• Multi-modality approach for comprehensive treatment offerings
• Customizable solutions for diverse patient needs
• Recurring revenue through repeatable procedures
• User-friendly design with intelligent controls
• Enhanced power and faster outcomes

• Adaptable platform that grows with your practice
• Comprehensive solution for today's most in-demand treatments
• Multiple revenue streams from one sophisticated system
• Cutting-edge technology backed by clinical validation

IgniteRF is an advanced body and facial solution indicated for procedures requiring soft tissue contraction, electrocoagulation, hemostasis, and fractional treatments. This workstation combines QuantumRF and Morpheus8 Burst technologies to deliver deep tissue treatments up to 60mm.

OptimasMAX is a multi-functional platform that gives you the ability to provide the most in-demand consumer procedures, including fractional radiofrequency (FRF), intense pulsed light (IPL), hair removal, and vascular treatments. The system integrates advanced Morpheus8 Burst technology, enhanced Lumecca Peak IPL, and intelligent thermal monitoring for consistent, optimal results.

Morpheus8 is a minimally invasive bipolar radiofrequency (RF) tissue treatment, delivering the deepest fractional treatments available, heating subdermal tissue up to 8mm (7mm + 1mm thermal profile). 

Define’s hybrid configuration of both technician operated and hands-free technologies address the complex topography of the face and enables customized combination procedures in all facial regions.

Contact us to learn how InMode can help you meet growing patient demand while maximizing your practice's potential.

Not all products are approved in all countries. Check availability and approved intended use with our local representative.

Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.

17 Hughes

Irvine CA 92618